eMedicine Specialties > Neurology > Neurological Infections
Neuroimaging in Neurocysticercosis: Multimedia
Updated: Jul 10, 2009
Multimedia
 | Media file 1: Neuroimaging in neurocysticercosis. CT scans showing different phases of neurocysticercosis.Top left: CT scan showing many calcifications and active cysts with scolices in both hemispheres.Top right: T1-weighted MRI showing 2 active cysts with the scolex in their interior (vesicular phase).Bottom left: Postcontrast CT scan showing a ring-enhancing cyst (colloidal phase) on left.Bottom right: Proton density-weighted MRI showing a thick capsule with adjacent scolex and perilesional edema (colloidal phase). |
 | Media file 2: Neuroimaging in neurocysticercosis. Natural history of neurocysticercosis.Top left: This CT scan shows a large occipital active cyst (vesicle phase), many calcifications, and small cortical cysts.Top right: After 18 months, the occipital cyst has been replaced by a calcification and the remaining cysts have disappeared.Bottom left: A single parietal nodular-enhancing lesion (transitional, nodular-granular phase) is shown.Bottom right: Six months later, the lesion has disappeared. |
 | Media file 3: Neuroimaging in neurocysticercosis. Noncontrast and contrast-enhanced CT scan of neurocysticercosisLeft: Normal noncontrast CT scanRight: After administration of the contrast medium, the CT scan of the same patient shows a single parietal nodular-enhancing lesion (transitional, nodular phase). |
 | Media file 4: Neuroimaging in neurocysticercosis. Cysticercotic encephalitis.Left: Contrast-enhanced CT scan showing multiple, small, nodular, and annular areas of abnormal enhancement in brain parenchyma.Right: Gadolinium-enhanced T1-weighted MRI showing hyperintense lesions. |
 | Media file 5: Neuroimaging in neurocysticercosis. Cysticercus cellulosae in neurocysticercosis. |
 | Media file 6: Treatment of Neurocysticercosis |
 | Media file 7: Neuroimaging in neurocysticercosis. Cysticercus cellulosae showing the invaginated scolex in neurocysticercosis. |
 | Media file 8: Neuroimaging in neurocysticercosis. Subcortical parenchymatous cysticercosis |
 | Media file 9: Neuroimaging in neurocysticercosis. Inflammatory reaction in parenchymatous cysticercosis. |
 | Media file 10: Neuroimaging in neurocysticercosis. Antiepileptic treatment for patients with first seizure due to neurocysticercosis. |
 | Media file 11: Neuroimaging in neurocysticercosis. Probability of seizure recurrence (Kaplan-Meier curve) after a first seizure in patients with NC as function of cysticidal treatment. |
More on Neuroimaging in Neurocysticercosis |
| Overview: Neuroimaging in Neurocysticercosis |
| Differential Diagnoses & Workup: Neuroimaging in Neurocysticercosis |
| Treatment & Medication: Neuroimaging in Neurocysticercosis |
| Follow-up: Neuroimaging in Neurocysticercosis |
 Multimedia: Neuroimaging in Neurocysticercosis |
| References |
| « Previous Page |
References
Caplan LR. How to manage patients with neurocysticercosis. Eur Neurol. 1997;37(2):124. [Medline].
Carpio A. Neurocysticercosis: an update. Lancet Infect Dis. Dec 2002;2(12):751-62. [Medline].
Carpio A, Escobar A, Hauser WA. Cysticercosis and epilepsy: a critical review. Epilepsia. Oct 1998;39(10):1025-40. [Medline].
Carpio A, Hauser WA. Neurocysticercosis and epilepsy. In: Singh G, Prabhakar S, eds. Taenia Solium Cysticercosis. Oxon, UK: CABI Publishing; 2002:211-20.
Carpio A, Hauser WA. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology. Dec 10 2002;59(11):1730-4. [Medline].
Carpio A, Kelvin EA, Bagiella E, Leslie D, Leon P, Andrews H. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry. Sep 2008;79(9):1050-5. [Medline].
Carpio A, Placencia M, Santillan F. A proposal for classification of neurocysticercosis. Can J Neurol Sci. Feb 1994;21(1):43-7. [Medline].
Carpio A, Santillan F, Leon P. Is the course of neurocysticercosis modified by treatment with antihelminthic agents?. Arch Intern Med. Oct 9 1995;155(18):1982-8. [Medline].
Correa D, Medina-Escutia, E. Host-parasite immune relationship in Taenia solium taeniosis and cysticercosis. In: Garcia HH, Martinez, SM eds. Taenia solium Taeniasis/Cysticercosis. 1999:15-24.
Das K, Mondal GP, Banerjee M, Mukherjee BB, Singh OP. Role of antiparasitic therapy for seizures and resolution of lesions in neurocysticercosis patients: an 8 year randomised study. J Clin Neurosci. Dec 2007;14(12):1172-7. [Medline].
Davis L. Neurocysticercosis and seizures: Avoiding the cost of antihelminthic treatment. Neurology. 2002;59:1669-71.
Del Brutto OH, Roos KL, Coffey CS, García HH. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med. Jul 4 2006;145(1):43-51. [Medline].
Dixon HBF, Lipscomb FM. Cysticercosis: an analysis and follow up of 450 cases. Med Res Council Special Reports. 1961;299:1-58.
Escobar A. The pathology of neurocysticercosis. Cysticercosis of Central Nervous System. 1983:27-54.
Estanol B, Corona T, Abad P. A prognostic classification of cerebral cysticercosis: therapeutic implications. J Neurol Neurosurg Psychiatry. Oct 1986;49(10):1131-4. [Medline].
Flisser A, Correa D, Evans CAW. Taenia solium cysticercosis: New revisited immunological aspects. In: Singh G, Prabhakar S, eds. Taenia Solium Cysticercosis. Oxon, UK: CABI Publish; 2002:24-44.
Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. Jan 15 2004;350(3):249-58. [Medline].
Garcia HH, Martinez M, Gilman R. Diagnosis of cysticercosis in endemic regions. The Cysticercosis Working Group in Peru. Lancet. Aug 31 1991;338(8766):549-51. [Medline].
Garg K, Singh K, Misra S. Single-enhancing lesions in Indians patients with seizures: a review. Epilepsy Res. 2002;59:1730-1734.
Garg RK, Kar AM, Jain S. Failure of albendazole therapy in two common types of parenchymal neurocysticercosis. J Assoc Physicians India. Oct 1995;43(10):706-7. [Medline].
Gogia S, Talukdar B, Choudhury V, Arora BS. Neurocysticercosis in children: clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases. Trans R Soc Trop Med Hyg. Jul-Aug 2003;97(4):416-21. [Medline].
Goodman KA, Ballagh SA, Carpio A. Case-control study of seropositivity for cysticercosis in Cuenca, Ecuador. Am J Trop Med Hyg. Jan 1999;60(1):70-4. [Medline].
Kramer LD. Medical treatment of cysticercosis--ineffective. Arch Neurol. Jan 1995;52(1):101-2. [Medline].
Kramer LD, Locke GE, Byrd SE. Cerebral cysticercosis: documentation of natural history with CT [published erratum appears in Radiology 1989 Oct;173(1):286]. Radiology. May 1989;171(2):459-62. [Medline].
Manreza ML. Neurocysticercosis in children. Trends in Pediatric Neurology. 1993;295-8.
Martinez HR, Rangel-Guerra R, Arredondo-Estrada JH. Medical and surgical treatment in neurocysticercosis a magnetic resonance study of 161 cases. J Neurol Sci. May 1995;130(1):25-34. [Medline].
McCormick GF, Zee CS, Heiden J. Cysticercosis cerebri. Review of 127 cases. Arch Neurol. Sep 1982;39(9):534-9. [Medline].
Mitchell WG, Crawford TO. Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment. Pediatrics. Jul 1988;82(1):76-82. [Medline].
Padma MV, Behari M, Misra NK. Albendazole in single CT ring lesions in epilepsy. Neurology. Jul 1994;44(7):1344-6. [Medline].
Pal DK, Carpio A, Sander JW. Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry. Feb 2000;68(2):137-43. [Medline].
Ramos-Kuri M, Montoya RM, Padilla A. Immunodiagnosis of neurocysticercosis. Disappointing performance of serology (enzyme-linked immunosorbent assay) in an unbiased sample of neurological patients. Arch Neurol. Jun 1992;49(6):633-6. [Medline].
Schantz PM. Cysticercosis in non-endemic countries: the example of United States. Teniasis/Cysticercosis por T. solium. 1996;277-86.
Singhal BS, Salinas RA. Controversies in the Drug Treatment of Neurocysticercosis. In: Singh G, Prabhakar S, eds. Taenia Solium Cysticercosis. Oxon, UK: CABI Publish; 2002:713-43.
Suss RA, Maravilla KR, Thompson J. MR imaging of intracranial cysticercosis: comparison with CT and anatomopathologic features. AJNR Am J Neuroradiol. Mar-Apr 1986;7(2):235-42. [Medline].
Saenz B, Ruiz-Garcia M, Jimenez E, Hernandez-Aguilar J, Suastegui R, Larralde C. Neurocysticercosis: clinical, radiologic, and inflammatory differences between children and adults. Pediatr Infect Dis J. Sep 2006;25(9):801-3. [Medline].
Teitelbaum GP, Otto RJ, Watanabe AT. MR imaging of neurocysticercosis. AJNR. 1989;10:709-18.
Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis. Jan 1989;159(1):100-2. [Medline].
White AC, Garcia HH. Recent Developments in the Epidemiology, Diagnosis, Treatment, and Prevention of Neurocysticercosis. Curr Infect Dis Rep. Dec 1999;1(5):434-440. [Medline].
Xiao ZX, Zhao CY, Liu YP. [Albendazole treatment in cerebral cysticercosis]. Chung Hua Nei Ko Tsa Chih. Feb 1986;25(2):100-2, 127. [Medline].
Zee CS, Segall HD, Destian S. MRI of intraventricular cysticercosis: surgical implications. J Comput Assist Tomogr. Nov-Dec 1993;17(6):932-9. [Medline].
Further Reading
Keywords
neurocysticercosis, pork tapeworm, taeniasis, Taenia solium, T solium, cysticercosis, imaging studies, antihelminthic treatment, parasite, parasitic infection
